Custom cancer vaccine tailored from Patient's own tumor tested in new trial
NCT ID NCT02600949
Summary
This early-stage study is testing a personalized vaccine made from a patient's own tumor cells and blood. It aims to see if creating and giving this custom vaccine is safe and possible for people with advanced pancreatic or colorectal cancer that has spread. The vaccine is designed to help the body's immune system recognize and attack the cancer cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IV PANCREATIC CANCER AJCC V6 AND V7 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.